| dc.contributor.author | Kiyan, ESEN | |
| dc.contributor.author | Toy, Hatice | |
| dc.contributor.author | Tulek, Baykal | |
| dc.contributor.author | Kiyici, Aysel | |
| dc.contributor.author | Narin, Cuneyt | |
| dc.contributor.author | Suerdem, Mecit | |
| dc.date.accessioned | 2021-03-03T13:50:08Z | |
| dc.date.available | 2021-03-03T13:50:08Z | |
| dc.date.issued | 2011 | |
| dc.identifier.citation | Tulek B., Kiyan E., Toy H., Kiyici A., Narin C., Suerdem M., "Anti-inflammatory and anti-fibrotic effects of sirolimus on bleomycin-induced pulmonary fibrosis in rats", CLINICAL AND INVESTIGATIVE MEDICINE, cilt.34, sa.6, 2011 | |
| dc.identifier.issn | 0147-958X | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_364e65cd-4d18-4feb-862b-16a2d7f648de | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/40674 | |
| dc.description.abstract | Purpose: Pulmonary fibrosis is a devastating disease with a poor prognosis. Although the diagnosis and pathophysiology of this disease have been better characterized over the past few years, there is no effective therapy for the disease. The aim of this study was to evaluate the anti-inflammatory and anti-fibrotic effects of sirolimus (SRL), which is a potential anti-fibrotic agent, by using bleomycin (BLM)-induced pulmonary fibrosis model in rats. | |
| dc.language.iso | eng | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | Tıbbi Ekoloji ve Hidroklimatoloji | |
| dc.subject | TIP, ARAŞTIRMA VE DENEYSEL | |
| dc.subject | Klinik Tıp | |
| dc.title | Anti-inflammatory and anti-fibrotic effects of sirolimus on bleomycin-induced pulmonary fibrosis in rats | |
| dc.type | Makale | |
| dc.relation.journal | CLINICAL AND INVESTIGATIVE MEDICINE | |
| dc.contributor.department | Selçuk Üniversitesi , , | |
| dc.identifier.volume | 34 | |
| dc.identifier.issue | 6 | |
| dc.contributor.firstauthorID | 55421 | |
